This is a prospective, non-significant risk, controlled, randomized, multi-center, masked, feasibility study to evaluate the safety and IOP-lowering effectiveness of negative pressure application (via the Mercury MPD) for lowering and titrating intraocular pressure (IOP) in severe open-angle glaucoma (OAG) patients. The study will be conducted at approximately three investigational sites in the United States. Between 60 and 100 subjects will be randomized to treatment. Treatment eyes will be administered two levels of negative pressure, calculated based on 50% and 75% of baseline IOP (as measured by pneumatonometry). One eye of each eligible subject will be randomized to receive negative pressure application with the MPD device; the contralateral eye will be used as a control and will be examined but will not undergo application of negative pressure. Subjects will be treated at each of the negative pressure levels for one hour. All study procedures will be conducted at one visit, and the subject will exit the study at the conclusion of the visit.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
DOUBLE
Enrollment
64
Negative Pressure Treatment via the Mercury Multi-Pressure Dial
Illinois College of Optometry
Chicago, Illinois, United States
Vance Thompson Vision
Sioux Falls, South Dakota, United States
R and R Eye Research, LLC
San Antonio, Texas, United States
IOP* reduction of ≥ 20% with 50% Negative Pressure for the treatment group vs. the control group
Feasibility to lower intraocular pressure inside the eye in 1 treatment session (1-day). Not a measure of glaucoma progression health outcome. Difference in IOP as measured via pneumatonometry with Excursion goggles worn immediately before vs. during application of negative pressure.
Time frame: Day 1
Mean IOP*reduction with 50% Negative Pressure for the treatment group vs. the control group
Feasibility to lower intraocular pressure inside the eye in 1 treatment session (1-day). Not a measure of glaucoma progression health outcome. \*Difference in IOP as measured via pneumatonometry with Excursion goggles worn immediately before vs. during application of negative pressure
Time frame: Day 1
IOP* reduction of ≥ 25% with 75% Negative Pressure for the treatment group vs. the control group
\*Difference in IOP as measured via pneumatonometry with Excursion goggles worn immediately before vs. during application of negative pressure
Time frame: Day 1
Mean IOP*reduction with 75% Negative Pressure for the treatment group vs. the control group
\*Difference in IOP as measured via pneumatonometry with Excursion goggles worn immediately before vs. during application of negative pressure
Time frame: Day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.